Stock analysts expect HealthEquity, Inc. (NASDAQ:HQY – Get a rating) will report sales of $202.72 million for the current quarter, according to Zacks. Five analysts have released earnings estimates for HealthEquity, with the highest sales estimate at $208.30 million and the lowest estimate at $200.14 million. HealthEquity reported sales of $184.20 million in the same quarter last year, suggesting a positive year-over-year growth rate of 10.1%. The company is expected to release its next results after the market closes on Monday, January 1.
On average, analysts expect HealthEquity to report sales of $825.88 million for the current fiscal year, with estimates ranging from $821.25 million to $830.91 million. For next year, analysts expect the company to record sales of $896.17 million, with estimates ranging from $884.50 million to $918.77 million. Zacks sales calculations are an average based on a survey of research companies that cover HealthEquity.
HealthEquity (NASDAQ:HQY – Get a rating) last announced its results on Tuesday, March 22. The company reported earnings per share of $0.09 for the quarter, meeting analyst consensus estimates of $0.09. HealthEquity posted a positive return on equity of 3.49% and a negative net margin of 5.85%. The company posted revenue of $203.30 million for the quarter, versus a consensus estimate of $199.27 million. In the same quarter of the previous year, the company achieved EPS of $0.30.
A number of stock analysts have published reports on the company. Bank of America raised its price target on HealthEquity from $63.00 to $70.00 in a Wednesday, March 23 report. StockNews.com upgraded HealthEquity from a “hold” rating to a “sell” rating in a Sunday, March 27 research report. Deutsche Bank Aktiengesellschaft raised its price target on HealthEquity from $62.00 to $66.00 and gave the stock a “buy” rating in a Thursday, March 24 research report. Barrington Research raised its target price on HealthEquity from $55.00 to $70.00 in a Wednesday, March 23 research report. Finally, Wells Fargo & Company began covering HealthEquity in a research note on Monday, April 11. They issued an “overweight” rating and a price target of $95.00 on the stock. One research analyst gave the stock a sell rating and thirteen gave the company’s stock a buy rating. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $76.71.
Hedge funds have recently changed their holdings in the company. LPL Financial LLC increased its holdings in HealthEquity by 0.6% in the fourth quarter. LPL Financial LLC now owns 34,062 shares of the company valued at $1,504,000 after acquiring 188 additional shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its stake in HealthEquity by 6.7% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 4,401 shares of the company valued at $297,000 after acquiring an additional 277 shares during the period. Amalgamated Bank increased its position in HealthEquity shares by 0.5% during the fourth quarter. Amalgamated Bank now owns 59,183 shares of the company worth $2,618,000 after purchasing an additional 290 shares during the period. Signaturefd LLC increased its position in HealthEquity shares by 44.3% during the first quarter. Signaturefd LLC now owns 954 shares of the company worth $64,000 after purchasing an additional 293 shares during the period. Finally, State of Michigan Retirement System increased its position in HealthEquity by 1.4% in the fourth quarter. State of Michigan Retirement System now owns 21,166 shares of the company worth $936,000 after purchasing 300 additional shares during the period. 97.44% of the shares are held by institutional investors and hedge funds.
Shares of HQY opened at $62.80 on Friday. The company has a market capitalization of $5.30 billion, a P/E ratio of -118.49, a P/E/G ratio of 5.04 and a beta of 1.08. The stock has a 50-day simple moving average of $63.51 and a two-hundred-day simple moving average of $56.14. The company has a debt ratio of 0.50, a current ratio of 2.29 and a quick ratio of 2.29. HealthEquity has a 1-year minimum of $36.81 and a 1-year maximum of $84.78.
HealthEquity Company Profile (Get a rating)
HealthEquity, Inc provides technology service platforms to consumers and employers in the United States. The Company offers cloud-based platforms for individuals to make healthcare savings and spending decisions, pay healthcare bills, compare treatment options and prices, receive benefits personalized and clinical information, earn wellness incentives, increase savings, and make investment choices; and health savings accounts.
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in HealthEquity right now?
Before you consider HealthEquity, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and HealthEquity wasn’t on the list.
Although HealthEquity currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here